Diabetes

Cortisol-blocking treatment significantly improves blood sugar control and weight in people with hard-to-treat Type 2 diabetes.

CagriSema significantly reduced body weight and HbA1c in adults with Type 2 diabetes in new Phase 3 trial.

Discover how zimislecel enables insulin independence in patients with Type 1 diabetes, showing strong efficacy in early clinical data.

Understand how diabetes raises risk of infection and complications post-hysterectomy.

Learn how high TEWL after healing is linked to twice the risk of DFU recurrence.

Dapagliflozin shows promise for treating MASH, improving liver outcomes without worsening fibrosis in a major trial.

A new patient-led weight maintenance programme outperforms standard care, offering scalable, effective obesity management.

Dual burden of diabetes and hypertension more than doubles cardiovascular death risk, especially in women, study finds.

Discover how TENS nerve stimulation offers effective pain and sleep relief for diabetic neuropathy.

Delaying statins raises cardiovascular risk in diabetes; timely treatment is essential to improve patient outcomes.

Research confirms Type 2 diabetes greatly increases risks of death, severity, and ventilation need in COVID-19 cases.

Diabetes significantly raises the risk of delirium, but metformin and intranasal insulin may offer protective effects.

Discover how adult-onset type 1 diabetes is linked to higher death rates and cardiovascular events, especially post-40 diagnosis.

New model predicts diabetes risk and recommends personalised prevention, including lifestyle changes or metformin, for diverse populations.

Learn how GLP-1 receptor agonists show promise in reducing alcohol consumption and aiding weight loss in obesity treatment.

A recent study utilizing UK Biobank data has identified a significant rise in new-onset mental health disorders—specifically depression, anxiety, and alcohol use disorders—among adults with metabolic diseases such as hypertension, diabetes, and obesity in the aftermath of the COVID-19 pandemic.

AI safely matches senior doctors in hospital insulin dosing for T2D, easing clinical load without compromising care.

Semaglutide significantly improves liver inflammation and fibrosis in MASH patients, offering new hope for clinical management.

Low-energy diets are safe in pregnancy with gestational diabetes but show no clinical benefit in weight or birth weight.

Read about how vitamin supplementation does not significantly influence the development or progression of Type 1 diabetes.

Switching to tirzepatide yields greater HbA1c and weight reductions than escalating dulaglutide in Type 2 diabetes.

Elevated triglycerides in well-controlled gestational diabetes linked to increased pregnancy risks, suggesting lipid monitoring may be crucial.

Mind-body exercises show promising benefits for type 2 diabetes, improving blood sugar, weight, and heart health markers.

Higher eGDR linked with lower mortality and cardiovascular risk in diabetes, offering promise for clinical risk stratification.

Newer diabetes drugs linked to reduced risk of dementia in older adults, real-world data shows promising results.

Study links metformin use to increased diabetic neuropathy risk in dose-dependent fashion.

Understand how gestational diabetes is linked to ADHD symptoms in children.

Immunotherapy shows promise for improving glycaemic control in children with Type 1 diabetes.

Higher muscle strength may offset genetic risk of Type 2 diabetes, offering a new route for prevention.

Roux-en-Y gastric bypass outperforms sleeve gastrectomy and adjustable gastric banding, study finds.

Long-term ICS use in COPD is linked to increased risks of Type 2 diabetes, pneumonia, fractures, and more.

Oral semaglutide reduces cardiovascular events in type 2 diabetes, independent of SGLT2i therapy, with no safety concerns.

A study has demonstrated the feasibility of a mobile health-supported home-delivered physical activity programme for individuals recently diagnosed with Type 2 diabetes.

A recent study explored impact of hypertension and type 2 diabetes on kidney structure, revealing similar damage in both conditions.

Semaglutide use in diabetic patients linked to increased risk of NAION after two years of treatment.

New research shows that animal and total protein intake could reduce the risk of gestational diabetes during pregnancy.

A new predictive model helps personalise glucose-lowering therapy for type 2 diabetes, improving glycaemic control and reducing complications.

Poor sleep quality in geriatric type 2 diabetes patients is linked to worse glycaemic control and complications.

Research suggests that automated insulin delivery (AID) systems may play a significant role in enhancing glucose management.

Pioglitazone/metformin FDC with dapagliflozin may provide effective and safe management for Type 2 diabetes. Read more!

Short sleep and snoring linked to higher Type 2 diabetes risk in women with a history of gestational diabetes.

New research has investigated how a combination of dapagliflozin and moderate calorie restriction can cause remission in Type 2 diabetes

People with a genetic risk for type 2 diabetes may face a greater threat to heart health if they spend too much time watching TV, according to a new study.

New research has confirmed that automated insulin delivery (AID) systems are both safe and effective for older adults with Type 1 diabetes.

A high-protein vegan diet rich in mycoprotein improves glycaemic control in Type 2 diabetes, comparable to an omnivorous diet.

Inadequate sleep duration and persistent late sleep onset are associated with significant fluctuations in blood glucose levels according to a recent study.

New findings shed light on the brain’s role as a critical control centre in the development of obesity and Type 2 diabetes.

New research uncovers explanation for higher rates of Type 2 diabetes in Asian Indian populations.

People with Type 1 diabetes can achieve the same positive outcomes using advanced insulin technology when trained by their PCPs or through telehealth as they would by visiting a specialist in person according to new study.

A recent genetic study has provided new insights into how glucagon-like peptide-1 (GLP-1) receptor agonists aid weight loss.

A novel heparanase inhibitor preserves vascular integrity in diabetes, preventing microvascular complications in the eye and kidney.

Study shows that engaging in moderate to vigorous physical activity during leisure time is associated with a reduced risk of Type 2 diabetes.

Study has shed light on a potential pathway for combating insulin resistance.

Researchers have found that sulforaphane, a chemical compound found in broccoli sprouts, can significantly improve blood sugar levels in people with prediabetes.

A recent study has uncovered a worrying link between diabetes and the rapid emergence of antibiotic resistance.

SGLT-2is and GLP-1RAs linked to lower COPD exacerbation risk in T2D patients, study finds.

Mitochondria dysfunction has been found to be involved in the development of diabetes in newly published research.

Plant-based monounsaturated fats may lower Type 2 diabetes risk, while animal-derived sources are linked to higher risk.

Study finds that a significant proportion of adults prescribed GLP-1 RAs for weight management discontinue treatment within a year.

Body-weight cycling significantly increases the risk of kidney disease in individuals with Type 1 diabetes, study finds.

Exercise shown to directly affect how the brain responds to insulin in new study.

Researchers have shown that sugary drink intake affects diabetes risk via gut microbiome.

Scientist develop new equation for detecting hyperfiltration that incorporates age but not body surface area.

A new study has confirmed that type 2 diabetes significantly increases the risk of major cardiovascular events, regardless of atherosclerosis severity.

Diabetes treatments linked to behavioural side effects in new research.

SGLT2 inhibitors significantly improves kidney health in a diverse group of Asian adults with Type 2 diabetes, study finds.

Continuous glucose monitors have been found to predict complications in patients with Type 1 diabetes.

Sotagliflozin offers significant benefits for individuals with Type 1 diabetes and chronic kidney disease, study finds.

New insights into gut receptors may offer new strategies to manage sugar intake.

Exploring the impact of ketogenic diets on metabolic health amongst patients with diabetes.

Intermittent fasting has been shown to be a safe method for weight loss, decreasing diabetes risk.

Cerebrovascular pathologic changes may not be linked to traditional cardiovascular risk factors such as hypertension, diabetes, or hyperlipidaemia.

Research has found that oral medication is less effective than insulin for gestational diabetes.

New research shows impact of blood glucose-lowering medication on patients with diabetes.

Significant association found between the Children’s Dietary Inflammation Index (C-DII) and prediabetes among adolescents.

Research shows risks of eating after 5pm.

Promising therapeutic target for diabetic cardiomyopathy found.

Groundbreaking role for endocannabinoids in regulating food intake, energy use, and body weight found.

New trial highlights power of empathy in diabetes management.

Scientists create a revolutionary implantable device capable of monitoring protein levels in the body in real time.

Consuming dark chocolate linked to reduced risk of type 2 diabetes, study finds.

Carrageenan, a widely used food additive, may worsen insulin resistance and inflammation in overweight individuals, a new study reveals, sparking concerns over its impact on metabolic health.

New study sheds light on relationship between vitamin D dose and Type 2 diabetes.

New factors found affecting glucose levels in Type 1 diabetes.

New research reveals a genetic predisposition to Type 2 diabetes amongst British Asian individuals.

A molecule known as LXA4 could serve as a potential treatment for heart disease caused by diabetes.

New understanding of the impact of gestational diabetes on infant growth revealed.

Novel findings pave the way for new diabetes treatments.

Study finds link between diabetes diagnosis at young age and dementia risk.

In 2023, semaglutide emerged as the top-selling drug in the USA, generating $13.8 billion in sales.

New research shows that diabetes rates have doubled to 800 million adults, but over half remain untreated.

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related hospitalisations.

The researchers found that overeating triggers a rapid increase in norepinephrine, a key stress hormone. This, in turn, over activates the sympathetic nervous system.

Limiting sugar intake during early life, including in utero, may significantly reduce the risk of developing Type 2 diabetes and hypertension in adulthood.

Meal timings may be linked to chronic health conditions, including increased risk of diabetes, amongst people who work night shifts.

Dysregulation of certain amino and fatty acids in late pregnancy could influence the risk of developing Type 2 diabetes

25-year-old woman with Type 1 diabetes in China has successfully undergone a stem-cell therapy that enabled her to produce her own insulin, reducing her reliance on injections.

Young people with obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss 10 years later.

Obesity, defined as abnormal or excessive fat accumulation, has more than doubled among adults since 1990

A Japan-based team has made strides in improving non-invasive blood glucose monitoring technology, a timely development as diabetes rates rise globally.

Researchers at Cardiff University have developed an AI tool that could help detect signs of Type 1 diabetes in children before they experience dangerous complications.

A real-world study has found that SGLT2 inhibitors and GLP-1 receptor agonists are more effective at reducing kidney complications in adults with Type 2 diabetes and moderate cardiovascular risk compared to DPP-4 inhibitors and sulfonylureas.

Gestational diabetes screening in low-income countries faces challenges due to the accessibility of oral glucose tolerance tests. A study suggests early-pregnancy HbA1c testing, could reduce OGTT reliance

Diabetes significantly raises the risk of non-ST segment myocardial infarction, with affected patients experiencing worse short- and long-term outcomes. Despite this, they often receive less invasive care.

A study shows that adolescents with prediabetes have a higher risk of developing gestational diabetes and adverse birth outcomes, highlighting the need for early intervention.

Study finds a plant-based diet and exercise outperform standard care in managing type 2 diabetes, improving glycaemic control and reducing medication use.

Diabetes has long been recognised as a risk factor for dementia, but new research reveals its connection to accelerated brain ageing

Circadian rhythm disruption has been strongly linked to the development of Type 2 diabetes.

Findings from the FLOW trial, the first dedicated kidney outcomes trial with semaglutide in patients with Type 2 diabetes and chronic kidney disease, were presented at EASD 2024.

New analysis from the SURPASS-4 trial identifies crucial factors for maintaining blood glucose control and weight loss with tirzepatide in patients with Type 2 diabetes.

A key study presented at EASD 2024 highlights that rapidly managing blood sugar in pregnant women with gestational diabetes reduces the risk of obesity in their children.

Time-restricted eating, limiting food intake to an 8-hour window, significantly improves blood sugar control in adults at risk of Type 2 diabetes, research from EASD 2024 shows.

The SCALE Kids trial has found that weight-loss drug liraglutide is safe and effective for children aged 6 to under 12 years living with obesity.

A study has confirmed a significant link between a diet that includes meat consumption and the risk of developing type 2 diabetes.

A new study has highlighted the strong bidirectional relationship between chronic diabetes complications and mental health disorders in individuals with diabetes.

A recent cohort study has highlighted the potential of tirzepatide to significantly improve clinical outcomes in patients with Type 2 diabetes.

Discover how the NHS Type 2 Diabetes Path to Remission (T2DR) programme, has led to significant weight loss and diabetes remission in participants.

Researchers at Cardiff University have identified that Ustekinumab may effectively manage the early stages of Type 1 diabetes in children and adolescents.

According to recent findings, individuals who develop Type 1 diabetes face a heightened risk of mental health disorders.

COVID-19 infection has been associated with a rapid progression to clinical type 1 diabetes in young individuals with presymptomatic disease, according to a recent study.